John W. Kunstman, MD; Debra A. Goldman, MS; Mithat Gönen, PhD, et al report in the February issue of the Journal of the American College of Surgeons (JACS) on their findings that adoption of pasireotide allowed for achievement of clinically significant abscess or pancreatic leak rate of 13.3 percent, approximating the effect observed in a randomized trial of pasireotide during routine surgical practice.
This article and all other JACS content is available on the JACS website.
